Newbury Pharmaceuticals AB (publ) (STO:NEWBRY)
Sweden flag Sweden · Delayed Price · Currency is SEK
3.130
+0.050 (1.62%)
Apr 30, 2025, 9:17 AM CET

STO:NEWBRY Ratios and Metrics

Millions SEK. Fiscal year is Sep - Aug.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Apr '25 Aug '24 Aug '23 Aug '22 Aug '21
Market Capitalization
75807887-
Market Cap Growth
-5.51%2.52%-9.92%--
Enterprise Value
62656548-
Last Close Price
3.083.304.004.44-
PS Ratio
1.802.177.6115.72-
PB Ratio
1.671.541.581.26-
P/TBV Ratio
-15.9521.124.73-
EV/Sales Ratio
1.491.766.358.70-
Asset Turnover
0.480.450.130.09-
Inventory Turnover
3.205.863.26--
Quick Ratio
1.011.272.045.633.57
Current Ratio
1.211.492.316.023.63
Return on Equity (ROE)
-31.34%-30.41%-32.89%-27.35%-
Return on Assets (ROA)
-9.15%-11.04%-14.17%-13.48%-
Return on Capital (ROIC)
-18.38%-17.86%-19.17%-16.30%-
Earnings Yield
-17.95%-19.24%-24.88%-16.92%-
Buyback Yield / Dilution
-21.82%-9.68%-9.68%--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.